Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study.
Kyung-Sang YuHyunwook RyuDongseong ShinMin-Kyu ParkJun Gi HwangSeol Ju MoonMin Gul KimEdward C KeystoneJosef S SmolenSungHyun KimYunJu BaeDaBee JeonJiYoung JangGoEun YangJiHun BaeJaeYong LeeGerd R BurmesterPublished in: Expert opinion on biological therapy (2024)
ClinicalTrials.gov: NCT05617183.